‘PMPS’ magazine published Nemera’s article about its innovation in nasal delivery
The February issue of the PMPS magazine includes the article “How Can Nasal Drug Delivery Devices Increase Patient Compliance and Safety?”
In this article, Nemera showcases its innovative devices for nasal delivery:
The majority of treatments via the nose are self-administered; therefore, nasal delivery systems can have a positive impact on compliance. Advances in devices and electronics are also opening up the possibility of adding features to increase patient adherence, such as a ‘do not forget me’ function with reminders through an app. For potent drugs, electronics improve patient safety while preventing the device from delivering multiple doses in a row, avoiding any overdosing.
This article is taken from Pharmaceutical Manufacturing and Packing Sourcer February 2020, pages 20-21. © Samedan Ltd
To learn more about our nasal and electronic devices, come to meet us on our booth C56 at Pharmapack 2020 in Paris.
The full issue of the magazine:
Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generics industries. Nemera offers a comprehensive portfolio of products and services across ophthalmology, nasal, inhalation, dermal, transdermal and parenteral delivery. Nemera’s vision is to be the most patient-centric drug delivery device company. Nemera always puts patients first, providing high-quality solutions that have a demonstrable impact on patients’ health
Nemera’s newly branded Insight Innovation Center, with offices in North America and Europe provides consultative services to support your overall device strategy. Providing user research, Human Factors, User Experience design, and Design for manufacturing, the Insight Innovation Center can help customers navigate their device strategy for both novel and platform solutions. Users are at the center of everything that we do in our effort to always put patients first.